Literature DB >> 9622311

Maternal regulation of fetal development and health in adult life.

K M Godfrey1.   

Abstract

Babies who are small or disproportionate at birth, or who have altered placental growth are now known to have increased rates of coronary heart disease, hypertension and non-insulin-dependent diabetes in adult life. These associations are thought to result from fetal 'programming', whereby a stimulus or insult at a critical, sensitive period of early life has permanent effects on the body's structure, physiology and metabolism. Small size at birth and disproportion in head size, length and weight appear to be surrogate markers for the actual influences that programme the fetus. These observations have prompted a re-evaluation of the maternal regulation of human fetal development. Recent studies suggest that the fetus may be considerably more sensitive to the materno-placental supply of nutrients than hitherto imagined. Adult cardiovascular disease may be a consequence of fetal adaptations invoked when the materno-placental nutrient supply fails to match the fetal nutrient demand. Understanding the maternal regulation of human fetal development could lead to public health measures that improve the adult health of future generations.

Entities:  

Mesh:

Year:  1998        PMID: 9622311     DOI: 10.1016/s0301-2115(98)00060-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  30 in total

1.  Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Christos Coutifaris; Thomas Molinaro; Kurt T Barnhart
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

Review 2.  Determinants of fetal growth.

Authors:  David A Sacks
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

3.  Moderately increased maternal dietary energy intake delays foetal skeletal muscle differentiation and maturity in pigs.

Authors:  Tiande Zou; Dongting He; Bing Yu; Jie Yu; Xiangbing Mao; Ping Zheng; Jun He; Zhiqing Huang; Yan Shu; Yue Liu; Daiwen Chen
Journal:  Eur J Nutr       Date:  2015-07-16       Impact factor: 5.614

4.  Early-life prevention of non-communicable diseases.

Authors:  John M Balbus; Robert Barouki; Linda S Birnbaum; Ruth A Etzel; Peter D Gluckman; Philippe Grandjean; Christine Hancock; Mark A Hanson; Jerrold J Heindel; Kate Hoffman; Génon K Jensen; Ann Keeling; Maria Neira; Cristina Rabadán-Diehl; Johanna Ralston; Kwok-Cho Tang
Journal:  Lancet       Date:  2013-01-05       Impact factor: 79.321

Review 5.  Fetal programming and early identification of newborns at high risk of free radical-mediated diseases.

Authors:  Serafina Perrone; Antonino Santacroce; Anna Picardi; Giuseppe Buonocore
Journal:  World J Clin Pediatr       Date:  2016-05-08

6.  Thoracic and abdominal aortas stiffen through unique extracellular matrix changes in intrauterine growth restricted fetal sheep.

Authors:  R Blair Dodson; Paul J Rozance; Carson C Petrash; Kendall S Hunter; Virginia L Ferguson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 8.  Gene expression in the placenta: maternal stress and epigenetic responses.

Authors:  Ciprian P Gheorghe; Ravi Goyal; Ashwani Mittal; Lawrence D Longo
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  Non-linear and gender-specific relationships among placental growth measures and the fetoplacental weight ratio.

Authors:  D P Misra; C M Salafia; R K Miller; A K Charles
Journal:  Placenta       Date:  2009-10-29       Impact factor: 3.481

Review 10.  One carbon metabolism in pregnancy: Impact on maternal, fetal and neonatal health.

Authors:  Satish C Kalhan
Journal:  Mol Cell Endocrinol       Date:  2016-06-04       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.